Why Nektar Therapeutics Stock Popped 6% on Friday todayheadline
The company said it has sufficient financial resources to fund its operations into early 2027. Biotech Nektar Therapeutics (NKTR 5.70%) ...
Read moreDetailsThe company said it has sufficient financial resources to fund its operations into early 2027. Biotech Nektar Therapeutics (NKTR 5.70%) ...
Read moreDetails
